Cargando…

Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors

Hepatocellular carcinoma (HCC) is a leading cause of mortality. Checkpoint inhibitors of programmed cell death protein‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have shown great efficacy, but lack biomarkers that predict response. Circulating tumor cells (CTCs) have promise as a liquid‐biopsy b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winograd, Paul, Hou, Shuang, Court, Colin M., Lee, Yi‐Te, Chen, Pin‐Jung, Zhu, Yazhen, Sadeghi, Saeed, Finn, Richard S., Teng, Pai‐Chi, Wang, Jasmin J., Zhang, Zhicheng, Liu, Hongtao, Busuttil, Ronald W., Tomlinson, James S, Tseng, Hsian‐Rong, Agopian, Vatche G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527695/ https://www.ncbi.nlm.nih.gov/pubmed/33024921 http://dx.doi.org/10.1002/hep4.1577

Ejemplares similares

Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells
por: Court, Colin M., et al.
Publicado: (2020)

Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
por: Chen, Jie-Fu, et al.
Publicado: (2016)

Hepatocellular carcinoma surveillance: current practice and future directions
por: Ahn, Joseph C., et al.
Publicado: (2022)

The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications
por: Sho, Shonan, et al.
Publicado: (2017)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Sun, Na, et al.
Publicado: (2020)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Impact of the Share 35 Policy on Perioperative Management and Mortality in Liver Transplantation Recipients
por: Lapisatepun, Warangkana, et al.
Publicado: (2021)

Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens
por: Sho, Shonan, et al.
Publicado: (2017)

Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations
por: Sun, Na, et al.
Publicado: (2022)

Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations (Adv. Sci. 14/2022)
por: Sun, Na, et al.
Publicado: (2022)

Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer
por: Stackpole, Mary L., et al.
Publicado: (2022)

Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients
por: Lee, Edward Wolfgang, et al.
Publicado: (2021)

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)

Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells
por: Dong, Jiantong, et al.
Publicado: (2019)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
por: O’Donnell, Jake S., et al.
Publicado: (2016)

Total neoadjuvant treatment and PD-1/PD-L1 checkpoint inhibitor in locally advanced rectal cancer
por: Xiao, Weiwei, et al.
Publicado: (2023)

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
por: Qin, Shuang, et al.
Publicado: (2019)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
por: Pesce, Silvia, et al.
Publicado: (2019)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
por: Hashimoto, Kazuhiko, et al.
Publicado: (2020)

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
por: Anand, Kartik, et al.
Publicado: (2020)

From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation
por: Mouw, Kent W., et al.
Publicado: (2018)

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
por: Ilcus, Cristina, et al.
Publicado: (2017)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
por: Wang, Xin, et al.
Publicado: (2019)

Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2019)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
por: Li, Qian, et al.
Publicado: (2022)

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis
por: Schneider, Stephanie, et al.
Publicado: (2017)

Intestinal Perforation Following Ileoscopy Through a Prolapsed Stoma in an Pediatric Intestinal Transplant Recipient With an Unrecognized Parastomal Hernia
por: Mehrotra, Pavni, et al.
Publicado: (2016)

The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
por: Wang, Qingshui, et al.
Publicado: (2017)

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
por: Wang, Dongxu, et al.
Publicado: (2019)

Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
por: Hashimoto, Kazuhiko, et al.
Publicado: (2021)

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
por: Tang, Qing, et al.
Publicado: (2022)

Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint
por: Gu, Tingxuan, et al.
Publicado: (2023)

Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
por: Zhou, Yanting, et al.
Publicado: (2023)

PD-1 and its ligands are important immune checkpoints in cancer
por: Dong, Yinan, et al.
Publicado: (2016)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tk7vilo190slaf6h70n2lbqvdn